SAB Biotherapeutics
SABS
SABS
34 hedge funds and large institutions have $56.3M invested in SAB Biotherapeutics in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
36% more funds holding
Funds holding: 25 → 34 (+9)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$23M | |
| 2 | +$8.85M | |
| 3 | +$8.85M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.73M |
| 5 |
SC
Sessa Capital
New York
|
+$3.5M |
Top Sellers
| 1 | -$29.9K | |
| 2 | -$20.8K | |
| 3 | -$7.2K | |
| 4 |
BlackRock
New York
|
-$1.34K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$234 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $3.14K |
|
|||
27
Citigroup
New York
| $1.67K |
|
|||
|
MCM
28
MAI Capital Management
Independence,
Ohio
| $437 |
|
|||
|
GI
29
GS Investments
Minneapolis,
Minnesota
| $402 |
|
|||
30
Morgan Stanley
New York
| $338 |
|
|||
31
JP Morgan Chase
New York
| $175 |
|
|||
32
Bank of America
Charlotte,
North Carolina
| $149 |
|
|||
|
SS
33
SBI Securities
Tokyo,
Japan
| $105 |
|
|||
|
HI
34
Harbour Investments
Madison,
Wisconsin
| $101 |
|
|||
35
Citadel Advisors
Miami,
Florida
| – |
|
|||
36
Creative Planning
Overland Park,
Kansas
| – |
|
|||
|
S
37
Sachetta
Lynnfield,
Massachusetts
| – |
|
|||
38
Raymond James Financial
St Petersburg,
Florida
| – |
|